Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Orchestra BioMed Holdings, Inc. (OBIO)

Compare
2.8600
+0.0400
+(1.42%)
At close: April 16 at 4:00:01 PM EDT
2.8600
0.00
(0.00%)
After hours: April 16 at 4:11:47 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for OBIO

Recent News: OBIO

View More
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates
Zacks 16 days ago
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
GlobeNewswire 16 days ago
Freightos And 2 Other Penny Stocks Worth Watching

Freightos And 2 Other Penny Stocks Worth Watching
Simply Wall St. 23 days ago
Orchestra BioMed to Present at Upcoming Investor Conferences

Orchestra BioMed to Present at Upcoming Investor Conferences
GlobeNewswire last month
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
GlobeNewswire last month
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference
GlobeNewswire 2 months ago
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
GlobeNewswire 2 months ago
US Penny Stocks Spotlight: AC Immune And Two Others To Consider

US Penny Stocks Spotlight: AC Immune And Two Others To Consider
Simply Wall St. 3 months ago
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds

Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds
Simply Wall St. 3 months ago
Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting
GlobeNewswire 4 months ago
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire 4 months ago
View More

Related Tickers

DNTH Dianthus Therapeutics, Inc.
18.98
-1.20%
 
ACRV Acrivon Therapeutics, Inc.
1.8500
-13.95%
 
AVTX Avalo Therapeutics, Inc.
4.6300
-5.51%
 
KRRO Korro Bio, Inc.
13.46
+0.45%
 
XBIT XBiotech Inc.
2.9600
-6.92%
 
GLUE Monte Rosa Therapeutics, Inc.
4.4100
-0.45%
 
PHVS Pharvaris N.V.
13.72
-1.58%
 
MVR0.BE Medivir AB
0.1406
+42.16%
 
ARDX.MX Ardelyx, Inc.
105.50
0.00%
 
RPD.MU Royalty Pharma plc
28.20
0.00%